SCHEMBL22459844

SCHEMBL22459844

C=C(C)C(=O)OCCOc1ccc(-c2ccc(-c3ccc(OCCOC(=O)C(=C)C)cc3)c(OCCOC(=O)C(=C)COC)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.42
▸ APEX1 P27695 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ EGFR P00533 2/20 0.40
▸ CHEK2 O96017 1/20 0.36
▸ CYP11B1 P15538 2/20 0.34
▸ CYP11B2 P19099 2/20 0.34
▸ PRKAB2 O43741 1/20 0.33
▸ PRKAG1 P54619 1/20 0.33
▸ PRKAA2 P54646 1/20 0.33
▸ PRKAA1 Q13131 1/20 0.33
▸ PRKAG3 Q9UGI9 1/20 0.33
▸ PRKAG2 Q9UGJ0 1/20 0.33
▸ PRKAB1 Q9Y478 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ PPARD Q03181 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459860 0.96 EGFR (0.43) POLBAPEX1HTTTDP1EGFR
SCHEMBL22459285 0.92 EGFR (0.39) POLBAPEX1HTTTDP1EGFR
SCHEMBL22459820 0.91 POLB (0.42) POLBAPEX1HTTTDP1CHEK2
SCHEMBL22459811 0.90 EGFR (0.40) POLBAPEX1HTTTDP1EGFR
SCHEMBL22459247 0.89 POLB (0.42) POLBAPEX1HTTTDP1CHEK2
SCHEMBL22459543 0.88 POLB (0.40) POLBAPEX1HTTTDP1CHEK2
SCHEMBL22459572 0.88 POLB (0.43) POLBAPEX1HTTTDP1CHEK2
SCHEMBL22459417 0.88 BACE1 (0.39) POLBAPEX1HTTTDP1CHEK2
SCHEMBL22459813 0.87 CHEK2 (0.36) POLBAPEX1HTTTDP1EGFR
SCHEMBL22459241 0.87 PDE4A (0.39) POLBAPEX1HTTTDP1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725764-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2020-10-21 — — EP disclosed
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 POLB 3467/4885APEX1 1393/4885HTT 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback